
We at OTEurope previously ran a headline stating "Lucentis receives DME approval in the EU". For the purpose of clarification, this referred to CHMP approvals alone. Full acceptance for Lucentis in Europe will require approval from EMEA.

We at OTEurope previously ran a headline stating "Lucentis receives DME approval in the EU". For the purpose of clarification, this referred to CHMP approvals alone. Full acceptance for Lucentis in Europe will require approval from EMEA.

Short-term saffron supplementation has been found to improve retinal flicker sensitivity in early age-related macular degeneration (AMD).

Pre-term genetic diagnosis with immediate laser treatment after birth could help prevent vision loss in people affected by Norrie?s disease.

In a recent study it has been reported that an intrastromal corneal ring segment implantation is a safe and effective treatment for keratoconus.

Media Kit

Media Kit Euro

Ophthalmology Times Europe is offering you the chance to win a 16 GB iPad.

Scientists from the Children's Hospital Boston, USA have revealed their achievement of the greatest regeneration to date in the mammalian optic nerve.

A recent study has revealed that higher consumption of fish or shellfish could help to protect eyes against advanced age-related macular degeneration (AMD).

Laser peripheral iridotomy (PI) results in significant angle widening and iris profile flattening at the temporal and nasal angles according to a study recently published.

Using a capsular tension ring (CTR) implantation has been found to have no consistent effect on refractive outcomes compared with routine phacoemulsification in highly myopic eyes.

A study has found that doppler ultrasound may be useful in monitoring and diagnosis of patients with suspected giant cell arteritis (GCA).

Cataract surgery and changes to blood pressure caused by sodium restriction has been shown to have no effect on retinal vascular diameter.

A new laser system designed to perform four incisions, the Catalys Precision Laser system, from OptiMedica has been shown to help surgeons achieve significant improvement in precision during several critical steps of cataract surgery.

Fight for Sight has awarded six £15,000 grants to support ophthalmic research in the UK.

Implanatation of multiple trabecular micro-bypass implants (iStent, Glaukos) in Schlemm's canal following phamoemulsification successfully and significantly reduced IOP for 12 months after implantation, as well as the number of medications required to maintain target IOP

Several algorithms help physicians base appropriate therapy on signs and symptons

Analyses of data from the Confocal Scanning Laser Ophthalmoscopy Ancilliary Study to the Ocular Hypertension Treatment study found rim area parameters changed significantly in the eyes that had progression to a primary open-angle glaucoma endpoint compared with eyes that did not.

Dr Zaluski examines the visual performance and ascertains the level of patient satisfaction with the multifocalDiffractiva Diff-s IOL

It has been demonstrated that autorefractometry is less accurate in eyes that have undergone LASIK when compared with non-operated eyes, according to a recent study published in the American Journal of Ophthalmology.

The potential complications associated with implantation of phakic IOLs may give cataract surgeons a few challenges, but problems can often be averted with proper sizing and vaulting.

Looking into post-injection endophthalmitus, which has become one of the most frequent causes of endophthalmitus.

A rare case of bilateral pigmented atrophic changes in the macular region associated with topiramate treatment for chorioathetosis in a young female is reported.

A new variation of femtosecond laser-assisted 'big bubble' deep anterior lamellar keratoplasty uses the laser to create an intrastromal channel serves as a pathway for the insertion of the air injection

A round up of new products

Avoiding permanent damage calls for more aggressive treatment, occasional 'scare' tactic

A review of the year in cataract & refractive, retina and glaucoma. Shows three industry experts view on their highs of the year and the changes they've experienced as well as what the future holds for 2011

Results from preclinical testing including a formal Good Laboratory Practice toxicity study, support the safety of a gene transfer agent, AAV2-sFLT01, when administered intravitreally. A phase I safety and tolerability study of this agent is currently underway.

Patients suffering from primary open-angle glaucoma (POAG) or ocular hypertension have been shown to respond better to travoprost than latanoprost according to a recent study.

Optos plc has announced its proposed acquisition of the entire issued shared capital of Opto Global Holdings for up to $14.75 million.